Cbre Investment Management Listed Real Assets LLC Sells 411,255 Shares of COPT Defense Properties $CDP

Cbre Investment Management Listed Real Assets LLC cut its stake in shares of COPT Defense Properties (NYSE:CDP) by 28.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,016,948 shares of the company’s stock after selling 411,255 shares during the period. Cbre Investment Management Listed Real Assets LLC’s holdings in COPT Defense Properties were worth $28,271,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in shares of COPT Defense Properties by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 17,127,858 shares of the company’s stock valued at $476,154,000 after acquiring an additional 128,583 shares during the period. Alliancebernstein L.P. increased its stake in shares of COPT Defense Properties by 16.8% in the third quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company’s stock valued at $245,771,000 after buying an additional 1,215,936 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of COPT Defense Properties by 7.7% in the third quarter. JPMorgan Chase & Co. now owns 3,566,073 shares of the company’s stock valued at $103,630,000 after buying an additional 253,558 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of COPT Defense Properties by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,149,130 shares of the company’s stock valued at $87,558,000 after buying an additional 17,049 shares in the last quarter. Finally, Channing Capital Management LLC increased its stake in shares of COPT Defense Properties by 21.0% in the third quarter. Channing Capital Management LLC now owns 2,913,596 shares of the company’s stock valued at $84,669,000 after buying an additional 506,593 shares in the last quarter.

COPT Defense Properties Price Performance

Shares of CDP stock opened at $31.62 on Tuesday. The stock has a 50-day moving average price of $31.74 and a 200 day moving average price of $30.84. The company has a quick ratio of 2.85, a current ratio of 2.85 and a debt-to-equity ratio of 1.63. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of 22.91 and a beta of 0.79. COPT Defense Properties has a 12 month low of $26.91 and a 12 month high of $33.33.

COPT Defense Properties (NYSE:CDP) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.34). The firm had revenue of $200.64 million during the quarter, compared to analyst estimates of $185.10 million. COPT Defense Properties had a return on equity of 10.02% and a net margin of 20.10%.COPT Defense Properties’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.65 earnings per share. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts expect that COPT Defense Properties will post 2.78 EPS for the current year.

COPT Defense Properties Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Tuesday, June 30th. COPT Defense Properties’s dividend payout ratio (DPR) is presently 92.75%.

Analyst Ratings Changes

A number of analysts have recently weighed in on CDP shares. Citigroup raised their target price on COPT Defense Properties from $29.00 to $34.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Truist Financial raised their target price on COPT Defense Properties from $31.00 to $33.00 and gave the company a “hold” rating in a research note on Tuesday, March 3rd. JPMorgan Chase & Co. raised their target price on COPT Defense Properties from $33.00 to $34.00 and gave the company a “neutral” rating in a research note on Friday, May 15th. Wells Fargo & Company raised their target price on COPT Defense Properties from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Monday. Finally, Weiss Ratings upgraded COPT Defense Properties from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, April 21st. Five investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $34.88.

Insider Activity

In other news, Director Robert L. Denton sold 3,922 shares of the company’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $32.38, for a total value of $126,994.36. Following the completion of the sale, the director directly owned 3,803 shares of the company’s stock, valued at $123,141.14. This represents a 50.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.66% of the company’s stock.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.